OverviewSemaglutide is a synthetic GLP-1 receptor agonist utilized in laboratory metabolic research involving incretin signaling pathways and peptide–receptor interactions. Research FocusResearchers study Semaglutide in models evaluating GLP-1–mediated intracellular cascades, metabolic regulation, and receptor-binding behavior. Mechanism of InterestIts structure supports prolonged GLP-1 receptor activation, enabling investigation of incretin-related biochemical signaling mechanisms. Compliance NoticeFor research only. Not for human consumption.